Peptomyc Company
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Investors
.png)
.png)
Total Funding:
22792000.0
Headquarters:
Barcelona, Catalonia, Spain
Funding Status:
Early Stage Venture
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Venture - Series Unknown
Technology:
Data-driven Technologies
Investor Type:
For Profit
Last Funding Date:
2022-01-18
Investors Number:
10.0
Founded Date:
2014-12-01
Industry:
Clinical Development